Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with coronavirus disease 2019 (COVID-19) has raised great concerns. The effect of NSAIDs on the clinical status of COVID-19 remains in question. Therefore, we performed a post-hoc analysis from the ORCHID trial. Patients with COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Sheng, Hongguang, Tang, Xiaoyi, Xia, Panpan, Li, Zhangwang, Xu, Minxuan, Ma, Jianyong, Shen, Yunfeng, Yu, Peng, Liu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618688/
https://www.ncbi.nlm.nih.gov/pubmed/36325468
http://dx.doi.org/10.3389/fcimb.2022.935280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618688/
https://www.ncbi.nlm.nih.gov/pubmed/36325468
http://dx.doi.org/10.3389/fcimb.2022.935280

Ejemplares similares